Clinical trial
Phase 1 Dose Finding Trial of MK-7075 in Children and Adults With Proteus Syndrome
NCT02594215 is registered in ClinicalTrials.gov with National Human Genome Research Institute (NHGRI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 1 Dose Finding Trial of MK-7075 in Children and Adults With Proteus Syndrome
- Lead sponsor
- National Human Genome Research Institute (NHGRI)
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- November 16, 2015
- Completion date
- June 24, 2022
- Enrollment
- 6 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.